vs

Side-by-side financial comparison of 3M (MMM) and Orchestra BioMed Holdings, Inc. (OBIO). Click either name above to swap in a different company.

3M is the larger business by last-quarter revenue ($6.0B vs $30.9M, roughly 195.0× Orchestra BioMed Holdings, Inc.). Orchestra BioMed Holdings, Inc. runs the higher net margin — 20.2% vs 10.8%, a 9.4% gap on every dollar of revenue. On growth, Orchestra BioMed Holdings, Inc. posted the faster year-over-year revenue change (12120.2% vs 1.3%). 3M produced more free cash flow last quarter ($2.0B vs $-2.3M). Over the past eight quarters, Orchestra BioMed Holdings, Inc.'s revenue compounded faster (606.2% CAGR vs -1.8%).

The 3M Company is an American multinational conglomerate operating in the fields of industry, worker safety, and consumer goods. Based in the Saint Paul suburb of Maplewood, the company produces over 60,000 products, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection film, electrical, electronic connecting, insulating materials, car-care products, electronic circuits, and optical films. Among its best-known consume...

Orchestra BioMed Holdings, Inc. is a clinical-stage medical technology company focused on developing novel, evidence-based therapeutic solutions for cardiovascular and other high-burden chronic diseases. It collaborates with leading healthcare stakeholders, operates primarily across North American and European markets, with core segments covering interventional cardiology and chronic disease care optimization.

MMM vs OBIO — Head-to-Head

Bigger by revenue
MMM
MMM
195.0× larger
MMM
$6.0B
$30.9M
OBIO
Growing faster (revenue YoY)
OBIO
OBIO
+12118.9% gap
OBIO
12120.2%
1.3%
MMM
Higher net margin
OBIO
OBIO
9.4% more per $
OBIO
20.2%
10.8%
MMM
More free cash flow
MMM
MMM
$2.0B more FCF
MMM
$2.0B
$-2.3M
OBIO
Faster 2-yr revenue CAGR
OBIO
OBIO
Annualised
OBIO
606.2%
-1.8%
MMM

Income Statement — Q1 2026 vs Q4 2025

Metric
MMM
MMM
OBIO
OBIO
Revenue
$6.0B
$30.9M
Net Profit
$653.0M
$6.2M
Gross Margin
40.7%
99.8%
Operating Margin
23.2%
21.8%
Net Margin
10.8%
20.2%
Revenue YoY
1.3%
12120.2%
Net Profit YoY
-41.5%
138.7%
EPS (diluted)
$1.23
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MMM
MMM
OBIO
OBIO
Q1 26
$6.0B
Q4 25
$6.1B
$30.9M
Q3 25
$6.5B
$861.0K
Q2 25
$6.3B
$836.0K
Q1 25
$6.0B
$868.0K
Q4 24
$6.0B
$253.0K
Q3 24
$6.3B
$987.0K
Q2 24
$6.3B
$778.0K
Net Profit
MMM
MMM
OBIO
OBIO
Q1 26
$653.0M
Q4 25
$577.0M
$6.2M
Q3 25
$834.0M
$-20.8M
Q2 25
$723.0M
$-19.4M
Q1 25
$1.1B
$-18.8M
Q4 24
$728.0M
$-16.2M
Q3 24
$1.4B
$-15.4M
Q2 24
$1.1B
$-16.0M
Gross Margin
MMM
MMM
OBIO
OBIO
Q1 26
40.7%
Q4 25
33.6%
99.8%
Q3 25
41.8%
94.3%
Q2 25
42.5%
94.5%
Q1 25
41.6%
94.9%
Q4 24
51.7%
77.1%
Q3 24
42.1%
93.1%
Q2 24
42.9%
94.3%
Operating Margin
MMM
MMM
OBIO
OBIO
Q1 26
23.2%
Q4 25
13.0%
21.8%
Q3 25
22.2%
-2359.2%
Q2 25
18.0%
-2311.8%
Q1 25
20.9%
-2179.8%
Q4 24
12.2%
-6591.7%
Q3 24
20.9%
-1655.7%
Q2 24
20.3%
-2167.0%
Net Margin
MMM
MMM
OBIO
OBIO
Q1 26
10.8%
Q4 25
9.4%
20.2%
Q3 25
12.8%
-2419.0%
Q2 25
11.4%
-2316.1%
Q1 25
18.7%
-2160.7%
Q4 24
12.1%
-6385.4%
Q3 24
21.8%
-1562.9%
Q2 24
18.3%
-2054.0%
EPS (diluted)
MMM
MMM
OBIO
OBIO
Q1 26
$1.23
Q4 25
$1.07
$0.28
Q3 25
$1.55
$-0.40
Q2 25
$1.34
$-0.50
Q1 25
$2.04
$-0.49
Q4 24
$1.33
$-0.42
Q3 24
$2.48
$-0.41
Q2 24
$2.07
$-0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MMM
MMM
OBIO
OBIO
Cash + ST InvestmentsLiquidity on hand
$3.7B
$106.5M
Total DebtLower is stronger
$10.9B
$15.0M
Stockholders' EquityBook value
$3.3B
$53.6M
Total Assets
$35.4B
$114.9M
Debt / EquityLower = less leverage
3.29×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MMM
MMM
OBIO
OBIO
Q1 26
$3.7B
Q4 25
$106.5M
Q3 25
$95.8M
Q2 25
$33.9M
Q1 25
$49.9M
Q4 24
$66.8M
Q3 24
$66.9M
Q2 24
$65.2M
Total Debt
MMM
MMM
OBIO
OBIO
Q1 26
$10.9B
Q4 25
$12.6B
$15.0M
Q3 25
$12.6B
$15.0M
Q2 25
$13.1B
$15.0M
Q1 25
$13.5B
$15.0M
Q4 24
$13.0B
$15.0M
Q3 24
$13.2B
Q2 24
$13.1B
Stockholders' Equity
MMM
MMM
OBIO
OBIO
Q1 26
$3.3B
Q4 25
$4.7B
$53.6M
Q3 25
$4.6B
$43.7M
Q2 25
$4.3B
$295.0K
Q1 25
$4.5B
$16.9M
Q4 24
$3.8B
$33.0M
Q3 24
$4.6B
$46.2M
Q2 24
$3.9B
$44.1M
Total Assets
MMM
MMM
OBIO
OBIO
Q1 26
$35.4B
Q4 25
$37.7B
$114.9M
Q3 25
$37.6B
$104.8M
Q2 25
$38.0B
$42.8M
Q1 25
$40.0B
$59.1M
Q4 24
$39.9B
$76.2M
Q3 24
$40.9B
$75.3M
Q2 24
$43.4B
$72.4M
Debt / Equity
MMM
MMM
OBIO
OBIO
Q1 26
3.29×
Q4 25
2.68×
0.28×
Q3 25
2.72×
0.34×
Q2 25
3.06×
50.85×
Q1 25
3.02×
0.89×
Q4 24
3.40×
0.46×
Q3 24
2.84×
Q2 24
3.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MMM
MMM
OBIO
OBIO
Operating Cash FlowLast quarter
$-2.3M
Free Cash FlowOCF − Capex
$2.0B
$-2.3M
FCF MarginFCF / Revenue
33.6%
-7.4%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-0.36×
TTM Free Cash FlowTrailing 4 quarters
$3.7B
$-49.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MMM
MMM
OBIO
OBIO
Q1 26
Q4 25
$1.6B
$-2.3M
Q3 25
$1.8B
$-14.6M
Q2 25
$-954.0M
$-15.5M
Q1 25
$-79.0M
$-16.6M
Q4 24
$1.8B
$-13.5M
Q3 24
$-1.8B
$-13.7M
Q2 24
$1.0B
$-10.2M
Free Cash Flow
MMM
MMM
OBIO
OBIO
Q1 26
$2.0B
Q4 25
$1.3B
$-2.3M
Q3 25
$1.5B
$-14.9M
Q2 25
$-1.2B
$-15.6M
Q1 25
$-315.0M
$-16.7M
Q4 24
$1.5B
$-13.6M
Q3 24
$-2.0B
$-13.8M
Q2 24
$752.0M
$-10.3M
FCF Margin
MMM
MMM
OBIO
OBIO
Q1 26
33.6%
Q4 25
21.8%
-7.4%
Q3 25
23.6%
-1725.9%
Q2 25
-18.3%
-1861.4%
Q1 25
-5.3%
-1927.2%
Q4 24
25.4%
-5392.9%
Q3 24
-32.3%
-1394.9%
Q2 24
12.0%
-1325.6%
Capex Intensity
MMM
MMM
OBIO
OBIO
Q1 26
Q4 25
4.0%
0.1%
Q3 25
3.3%
36.0%
Q2 25
3.3%
4.1%
Q1 25
4.0%
12.9%
Q4 24
4.8%
41.9%
Q3 24
3.9%
6.9%
Q2 24
4.3%
13.8%
Cash Conversion
MMM
MMM
OBIO
OBIO
Q1 26
Q4 25
2.74×
-0.36×
Q3 25
2.11×
Q2 25
-1.32×
Q1 25
-0.07×
Q4 24
2.50×
Q3 24
-1.30×
Q2 24
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MMM
MMM

Safety and Industrial business segment$2.9B49%
Transportation and Electronics business segment$1.8B31%
Consumer business segment$1.1B19%
Corporate$121.0M2%

OBIO
OBIO

Segment breakdown not available.

Related Comparisons